BetterLife Pharma Inc. (BETRF)

BetterLife Pharma Cash Flow Statement

Financials in millions CAD. Fiscal year is February - January.

Operating Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Apr 30, 2026	Jan 31, 2026	Jan 31, 2025	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022
Net Income	-1.89	-1.5	-3.52	-2.89	-9.02	-12.16
Depreciation & Amortization	-	-	-	-	0.02	0.02
Stock-Based Compensation	0.29	0.17	2.05	0.5	3.94	1.35
Other Operating Activities	-0.21	-0.51	-1.3	-0.41	0.12	0.91
Change in Accounts Receivable	0	0.01	0.03	-0.02	0.31	0.18
Change in Accounts Payable	0.2	0.24	0.11	-0.7	2.21	-1.16
Change in Income Taxes	-	-	-	-	-0.16	0.17
Change in Other Net Operating Assets	0.76	0.96	0.62	1.05	1.07	-0.51
Operating Cash Flow	-0.85	-0.63	-2.02	-2.47	-1.5	-11.2
Operating Cash Flow Growth	-	-	-	-	-	-

Financing Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Apr 30, 2026	Jan 31, 2026	Jan 31, 2025	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022
Short-Term Debt Issued	-	0.41	-	-	-	-
Long-Term Debt Issued	-	-	1.22	0.3	-	0.12
Total Debt Issued	0.41	0.41	1.22	0.3	-	0.12
Short-Term Debt Repaid	-	-	-	-	-	-0.25
Long-Term Debt Repaid	-	-0	-	-	-	-
Total Debt Repaid	-0.01	-0	-	-	-	-0.25
Net Debt Issued (Repaid)	0.4	0.41	1.22	0.3	-	-0.13
Issuance of Common Stock	0.46	0.22	0.75	2.2	0.72	11.47
Other Financing Activities	-	-	0.02	-	0.61	-0.1
Financing Cash Flow	0.86	0.63	1.99	2.5	1.34	11.23

Net Cash Flow

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Apr 30, 2026	Jan 31, 2026	Jan 31, 2025	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022
Foreign Exchange Rate Adjustments	0	0	0	-0	0	-0.01
Net Cash Flow	0.01	0	-0.03	0.03	-0.17	0.02

Free Cash Flow

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Apr 30, 2026	Jan 31, 2026	Jan 31, 2025	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022
Free Cash Flow	-0.85	-0.63	-2.02	-2.47	-1.5	-11.2
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Per Share	-0.01	-0.00	-0.02	-0.02	-0.02	-0.15
Levered Free Cash Flow	-0.69	-1.55	-1.65	-1.84	2.13	-6.18
Unlevered Free Cash Flow	-0.57	-1.41	-1.45	-1.81	2.17	-6.14

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Apr 30, 2026	Jan 31, 2026	Jan 31, 2025	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022
Cash Interest Paid	0.01	0.01	0.03	-	-	-
Change in Working Capital	0.96	1.21	0.75	0.32	3.43	-1.32

Data Source: S&P Global Market Intelligence Last updated: Apr 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 28, 2026

Data Sources Report a data error